News - SpermVital

Announcement - new R&D manager appointed

We are pleased to announce the appointment of Dr. Marja Mikkola as our new R&D Manager in SpermVital.
She is a veterinarian from Helsinki University, Finland and holds a PhD from the same institution. She will be a great asset to the SpermVital team with her broad experience on Assisted Reproduction Technologies (ARTs) in cattle, with special emphasis on female fertility and embryo technologies as well as the application of sex-sorted semen. Her responsibilities will be to further document t...

03.11.2022

Great results from Austrian study

In the December issue of the Flechvieh Austria magazine there was an article presenting the results of a Master thesis done by Genostar in Austria.
The study that the thesis is based upon, refers to inseminations from 2015 to 2019. The use of the SpermVital semen in the study show on average a 6% higher NRR on heifers and 4,4% higher on cows. The result was even greater on repeat breeders, with a difference of up to 8,5% on animals with more than three inseminations The results from Genostar...

01.26.2021

VIKINGGENETICS will launch SpermVital

Vikinggenetics and SpermVital have signed an agreement where Vikinggenetics will launch SpermVital's unique technology on their own genetics.
VikingGenetics is a co-operative owned by 20,000 dairy and beef farmers in Denmark, Sweden, and Finland. They are experiencing a significant demand both in the Scandinavian markets as well as in the European market for the SpermVital technology. The SpermVital technology already has a significant market share in Europe and this agreement will give the...

12.15.2020

New Research Project

SpermVitals project "Novel sperm immobilization technology for large scale production of bull semen doses" was awarded 13.5 million NOK from The Research Council of Norway

10.01.2020

PhD in reproductive biology

Halldor Felde Berg from SpermVital has defended his PhD in reproductive biology
The overall aim of the PhD thesis was to acquire more knowledge about the SpermVital (SV) alginate gel, particularly concerning dissolution, sperm quality, and fertility following insemination. Also, the response of Norwegian Red heifers and cows to estrous synchronization and induction of ovulation was assessed. The findings of the thesis demonstrated a competitive reproductive performance of SV processed semen...

06.04.2020

Great results with SpermVital in Turkey

The results fom the Field Trial in Turkey shows a 12 % higher pregnancy rate for SpermVital compared to regular semen.
The aim of this study was to investigate the effect of SV technology on conception rates in repeat breeder multiparous dairy. Seventy-nine Holstein cows from a private dairy farm were included in the study, and these animals were cows that had failed to conceive from at least 3 regularly spaced services (repeat breeders) The cows were synchronized by 2 injections of a PGF2α,...

12.12.2019

SpermVital is performing well in Austria

At the European conference for station veterinarians, AI-vet, in Denmark in October, Dr. Friedrich Führer from the Austrian breeding company Genostar presented field data from the use of SpermVital in the Austrian market.
The company has analyzed field data from 32 herds that have used SpermVital.The data shows that on average SpermVital and regular processed semen is giving the same result in the field, but that there are also individual differences between the farms. Experience from other...

11.01.2019

New field trial with Masterrind

During the summer and fall of 2019, Masterrind has conducted a field trial where the purpose was to test SpermVital®-semen in comparison with ordinary semen.
The trial gave strong indications that early insemination with SpermVital®-semen has a positive effect on the Non Return Rate. Below are the results from the trial. The field trial was conducted independently by Masterrind, with doses originally produced for sale. The trial included 5 farms. All farms used Heatime systems as a basis for...

10.31.2019

PhD in immunology

Heidi Spång, scientist in SpermVital has defended her PhD in immunology
The main thesis of the PhD was to show that vaccines can be made more effective if antigens from infectious agents are connected to targeting units that bind specialized immune cells in our body. Heidi Spång and co-workers have developed a new heterodimeric platform for targeted DNA vaccines that can have two different targeting units and two different antigens. This new vaccine platform provides more flexibility for...

09.20.2019

The Icelandic farmers are very happy with SpermVital

The first field data is available, one year after the launch of SpermVital in Iceland.
The Icelandic are very happy with the results so far. They wish they had sold even more doses than what they have sold so far, but the results are good. For Heifers, where SpermVital has been used quite a lot, they are seeing a non-return rate of 80%. For Cows they are seeing a non-return rate between 56-74%, which they describe as very good! Their conclusion in regards to the use of SpermVital is that it i...

03.18.2019

4% increase in Non-return rate with SpermVital in Belgium

The Walloon Breeding Association (AWE) is the largest AI company in Belgium. They launched SpermVital on their Belgian Blue genetics in March 2018.
After 6 months in the market, the SpermVital semen is showing an increased non-return rate by 4%. The SpermVital semen is compared to ordinary sperm doses from the same bulls in the same period. The management of the company is very pleased with the result, although they emphasize that it is after all a limited number of inseminations. AWE will...

01.25.2019

PhD in reproductive biology

Fride Berg Standerholen, scientist in SpermVital has defended her PhD in reproductive biology
The main goal of the PhD thesis was to gain more knowledge of flow cytometric assessment of semen and procedures for sperm quality assessment. Sperm functionality was assessed in relation to bull semen preservation methods and fertility. One of the main findings was that there were differences in selected sperm function parameters between standard Biladyl (B) and immobilized SpermVital (SV) processed...

11.09.2018

High customer satisfaction when using SpermVital in Norway

Geno recently conducted a customer survey among Norwegian farmers to determine the use of SpermVital in the Norwegian market.
The survey shows that 90 percent of all milk producers have used SpermVital in 2018 and 84% of those who have used SpermVital are satisfied or very satisfied with the technology. The survey shows that the Norwegian farmers mostly use SpermVital under the following circumstances: 1. Early Insemination (increase flexibility) 2. Replace double insemination 3. Problem cows ...

04.25.2018

BVN is launching SpermVital

The German breeding company BVN will offer SpermVital semen from their bulls from 2018
BVN is the largest breeding company on Flechvieh in Germany. BVN will start to offer SpermVital from a small number of proven bulls and expand the range of bulls gradually. SpermVital is proud that BVN has chosen to apply the technology and that they see the benefit of increasing the life span of sperm cells.

01.15.2018

SpermVital gives higher fertility rate

During the DVG Vet Congress in Berlin a study done by Dr. Alper Koçyiğit, DVM, PhD, University of Cumhuriyet, Turkey, was presented.
The title of the study was “Performance of Spermvital Technology on Pregnancy Rate in Repeat Breeder Dairy Cows” The study showed that SpermVital semen provided a 12% higher fertility rate than conventional semen.

01.12.2018

2’nd patent being granted

SpermVitals second patent is now in the process of being granted in several countries. USA and Japan has recently approved the patent.
SpermVital applied for its first patent in 2008. This patent has been approved in the countries where an application was filed, all together more than 40 countries around the world. The patent is valid in all the biggest meat and milk producing countries. The second patent application was filed in 2012 and has gone through a rigid process with investigations i...

11.20.2017

SpermVital signed an agreement with the Icelandic company Nautastod Bændasamtaka

SpermVital has entered into an agreement with the Icelandic breeding company Nautastod Bændasamtaka regarding the use of SpermVital technology in Iceland.
Iceland has its own breed that the first settlers brought with them over 1000 years ago. Since then, very few cattle has been imported to Iceland. Currently, there are about 70,000 cattle in Iceland, of which 25,000 milk cows. Nautastod Bændasamtaka will use SpermVital technology in its efforts to preserve its unique genetic heritage.

11.02.2017

SpermVital in Belgium

SpermVital has signed an agreement in Belgium with The Walloon Breeding Association (AWE)
The Walloon Breeding Assoiation is the largest AI company in Belgium and will start selling SpermVital on their breed Belgian Blue in January 2018. They currently sell around 4 million doses worldwide.

11.02.2017

ISO certified

SpermVital recently got certified according to ISO 9001:2015
This certification confirms that we maintain an international standard related to systematic quality work and quality management. The quality management system contains objectives, plans, activities and results of all the processes in SpermVital, including: • Management • Research and Development • Production • Sales and Marketing

08.25.2017

SCIENTIFIC ARTICLE

New scientific article published in the Reproduction in Domestic Animals Journal
In the July 9, 2017 issue of Reproduction in Domestic Animals Journal SpermVital's article "Reproduction performance of immobilized cryopreserved bovin semen used for timed artifiscial insemination" was published. Below is the abstract of the article. Alm-Kristiansen AH1,2, Dalen G3,4, Klinkenberg G5, Bekk L2, Thorkildsen LT2, Waterhouse KE2, Kommisrud E1,2. The SpermVital® technology comprises embedding of...

08.24.2017

Masterrind will launch SpermVital

Masterrind will offer the SpermVital technology on their semen doses from the fall of 2017.
Masterrind is the largest bovine breeding company in Germany with a total sale of 3 million doses annually. Masterrind will offer the SpermVital technology on a number of bulls of the Holstein breed and on a number of beef bulls. Masterrind has experienced that customers are asking for the SpermVital technology and will therefore, launch it in August. SpermVital will give the farmers a bigger window for...

05.11.2017

SpermVital in Germany

SpermVital has signed an agreement with Alpengenetik in Germany.
Alpengenetik is a combination of four genetic companies in Germany and Austria. They have about 230 000 inseminations yearly on Braunvieh in their area and export around 230 000 doses. Alpengenetik will launch SpermVital in the late fall of 2016 and during the month of November there will be a launch meeting with German and Austrian veterinarians to further educate them on the benetfits of SpermVital.

10.27.2016

Expanding in Austria

Oberösterreichische Besamungsstation GmbH in Hohenzell is also launching SpermVital in Austria and exporting SpermVital together with Genostar through Genetic Austria.
The SpermVital production team has already been to the laboratory in Hohenzell to produce SpermVital doses for both the domestic and international market. Currently, both Genostar and Oberösterreichische Besamungsstation have launched SpermVital and therefore, the farmers in Austria will have access to SpermVital on a variety of...

04.12.2016

SpermVital in Austria

Genostar will launch the SpermVital technology in Austria this fall.
The SpermVital production team will travel to Austria for production before the summer to plan for the market launch. The farmers in Austria will finally be getting the advantages of the SpermVital technology with increased flexibility and the ability of grouping inseminations together. The SpermVital technology will also help increase the pregnancy rates on repeat breeders. Genostar will sell the SpermVital technology on bot...

05.28.2015

New research project through Regional Research Funds in Norway

SpermVitals project «New products for improved cost-effective production of cryopreserved semen with high fertilization ability» was granted through the Regional research funds in Norway this summer.
The project is a collaboration between SpermVital, Cryogenetics, SINTEF and Geno. SpermVital and Cryogenetics offers products and services within artificial insemination for the national and international markets for cattle and fish respectively. Both companies experiences an increased demand and ...

11.26.2014

SpermVital from young bulls

SpermVital from young bulls is for the first time being launched in Norway and the insemination technicians and veterinarians are currently receiving their first available SpermVital doses from these young bulls.
There are 1 750 doses produced of each young bull in Norway, and currently 300 of these doses are now being produced with the SpermVital technology. The bulls are distributed through 5 different groups throughout the year, and the first group is currently being distributed. The added...

09.01.2014

SpermVital has been granted funding for a new research project in Norway

SpermVital semen partly dissolved in the alginate under in vivo like conditions after 18 hours.

The projects is through the Regional research funds in Norway (Inland) and entitled "Immobilization of sperm cells prior to cryopreservation for gradual release over time in vivo, increased sperm longevity and improved fertility."
The fundamental idea of this project is to develop a new and improved SpermVital product, which provides further increased sperm longevity and improved fertility. Through this project, there will be research on immobilization and freezing technology, development of...

05.12.2014

SPERMVITAL IN SPAIN

As of March 1, Aberekin started selling SpermVital semen produced on 15 selected bulls including both dairy and beef breeds in Spain.
Aberekin believes that the Spanish dairy farmers will benefit greatly from the SpermVital technology by increasing pregnancy rates or by increasing their overall flexibility as well as giving farmers an option to inseminate early. Being able to inseminate early will reduce inseminations during times that are not optimal and also provide opportunities to group mo...

04.07.2014

SUCCESS FOR SPERMVITAL AND SWISSGENETICS

October first, Swissgenetics successfully launched SpermVital on most breeds in Switzerland and on the breed Brown Swiss internationally. The sales are above expectations and the demand among the Swiss farmers is very high. The Swiss farmers are benefiting greatly from the SpermVital technology by increasing the pregnancy rates on repeat breeders. Furthermore, the farmers are also given more flexibility due to the option of inseminating early. They can also group more of the inseminations...

01.07.2014

Minister of Agriculture visits SpermVital

Researcher Anne Hege Alm-Kristiansen and Minister of Agriculture Mr. Trygve Slagsvold Vedum

SpermVital hosted a meeting with the Norwegian Minister of Agriculture and Food, Mr. Trygve Slagsvold Vedum on June 24th. The minister visited our laboratory to get an insight of the company’s technology and research. The Scientific researchers Anne Hege Alm-Kristiansen and Godlove Bai demonstrated the difference between SpermVital semen and ordinary semen and showed him how we analyze semen and what determines the quality of semen. He also got an insight in how we work to develop the...

06.26.2013

Boosting conception rates with SpermVital

In the May 2013 issue of British Dairying there is an article on the impressive improvements in conception rates that producers are starting to see with the use of SpermVital. “Conception rates for conventional black or white herds are typically around 35% and in comparison we’re consistently recording rates of 60% or better where the technology has been used” says Wes Bluhm, the managing director of Geno UK . SpermVital is currently available in the UK on Norwegian Red Sires and is sold...

06.14.2013

Increased markedshare for SpermVital in Norway

SpermVital increases the odds of a successful fertilization. Here Norwegian Red cows in Norway. Photo: Solveig Goplen, Geno

The overall marketshare for SpermVital in Norway has increased from around 12 percent in 2012 to 15,8 percent so far in 2013.
SpermVital is available in about half of the Norwegian Elite bulls and the overall marketshare within the available bulls is around 40 percent. The use of SpermVital in Norway is recommended within these areas: Early insemination, Increase flexibility, Uncertain heat signs, In cows that return to heat

04.17.2013

Holstein with SpermVital in Poland

PH Konrad and SpermVital have finalized a contract regarding the right to sell Holstein SpermVital semen in Poland.
PH Konrad is the largest importer of semen in Poland and represents several of the large international A.I companies on the Polish market. They have their own sales force and also their own independent distribution net and they sell to both farmers, veterinarians and A.I. technicians in the Polish market.

01.08.2013

Swissgenetics will launch SpermVital

As of October 2013, Swissgenetics will start selling SpermVital semen produced on a few selected bulls from several breeds.
The preliminary plan is to launch SpermVital on the following breeds: Holstein Brown Swiss Red Holstein Simmenthal Swissgenetics believes that Swiss dairy farmers will benefit greatly from the SpermVital technology by increasing pregnancy rates on repeated breeders. Furthermore, the farmers will be given more flexibility as well as an option to inseminate early to reduce...

12.10.2012